Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-7-11
pubmed:databankReference
pubmed:abstractText
CHEK2 (previously known as "CHK2") is a cell-cycle-checkpoint kinase that phosphorylates p53 and BRCA1 in response to DNA damage. A protein-truncating mutation, 1100delC in exon 10, which abolishes the kinase function of CHEK2, has been found in families with Li-Fraumeni syndrome (LFS) and in those with a cancer phenotype that is suggestive of LFS, including breast cancer. In the present study, we found that the frequency of 1100delC was 2.0% among an unselected population-based cohort of 1,035 patients with breast cancer. This was slightly, but not significantly (P=.182), higher than the 1.4% frequency found among 1,885 population control subjects. However, a significantly elevated frequency was found among those 358 patients with a positive family history (11/358 [3.1%]; odds ratio [OR] 2.27; 95% confidence interval [CI] 1.11-4.63; P=.021, compared with population controls). Furthermore, patients with bilateral breast cancer were sixfold more likely to be 1100delC carriers than were patients with unilateral cancer (95% CI 1.87-20.32; P=.007). Analysis of the 1100delC variant in an independent set of 507 patients with familial breast cancer with no BRCA1 and BRCA2 mutations confirmed a significantly elevated frequency of 1100delC (28/507 [5.5%]; OR 4.2; 95% CI 2.4-7.2; P=.0002), compared with controls, with a high frequency also seen in patients with only a single affected first-degree relative (18/291 [6.2%]). Finally, tissue microarray analysis indicated that breast tumors from patients with 1100delC mutations show reduced CHEK2 immunostaining. The results suggest that CHEK2 acts as a low-penetrance tumor-suppressor gene in breast cancer and that it makes a significant contribution to familial clustering of breast cancer-including families with only two affected relatives, which are more common than families that include larger numbers of affected women.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10548311, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10617473, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10673500, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10673501, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10724175, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10854948, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10973490, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10987268, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-10995809, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11053450, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11100718, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11237395, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11248330, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11252893, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11431331, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11443730, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11479205, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11562114, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11593395, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11699418, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11719428, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11733767, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11746983, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11857015, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-11967536, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-8434605, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-9361038, http://linkedlifedata.com/resource/pubmed/commentcorrection/12094328-9836640
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0002-9297
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
432-8
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
pubmed:affiliation
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't